U.S. markets closed

Second Sight Medical Products, Inc. (EYES)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4300-0.0900 (-2.56%)
At close: 4:00PM EDT
Full screen
Loading interactive chart...
  • Business Wire

    Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

    LOS ANGELES, August 11, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announces that the Company received a grant supplement from the National Institutes of Health (NIH) to fund a qualitative study to gather critical insights into how profoundly blind people weigh the risks and benefits of visual neuroprostheses

  • Business Wire

    Second Sight Medical Products Announces Closing of Public Offering

    LOS ANGELES, June 25, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the closing of its previously announced underwritten public offering of 11,500,000 shares of its common stock at a public offering price of $5.00 per share, which includes 1,500,000 shares sold upon full exercise of the underwrit

  • Business Wire

    Second Sight Medical Products Announces Pricing of Public Offering

    LOS ANGELES, June 23, 2021--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the pricing of its underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $5.00 per share, for gross proceeds of $50,000,000, before deducting underwriting discounts, commissions and o